Waters Acquires Blue Reference for $14M, Pays $3M to Settle IP Dispute | GenomeWeb

NEW YORK (GenomeWeb News) – Waters said in its Form 10-Q for the second quarter that it has acquired software firm Blue Reference for $14 million in cash.

In its document filed Friday with the US Securities and Exchange Commission, the company also disclosed a $3 million payment to settle litigation alleging patent infringement by Waters.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.